title: Cyclosporine formulations: is there really a difference?
authors: Transplant Unit, Rizk Hospital, Beirut, Lebanon.
authors: M A
authors: MA
authors: Masri
authors: A
authors: A
authors: Stephan
authors: A
authors: A
authors: Barbari
authors: S
authors: S
authors: Rizk
authors: H
authors: H
authors: Kelany
authors: G
authors: G
authors: Kamel
mesh_terms: D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine